The Children’s Tumor Foundation is pleased to inform you about a new publication titled “Health Supervision for Children with Neurofibromatosis Type 1.” This is a joint effort between the American Academy of Pediatrics and the American College of Medical Genetics and Genomics. We hope you will join CTF in spreading the word about this great resource (link here). The main focus is to provide guidance to pediatricians and other specialists to better identify a child who might have NF1, understand the variability of NF1 signs and symptoms, and recognize and treat NF1-related concerns. This highly anticipated publication is an updated document from the original pediatric guidelines published in 2008 and was created by a team of dedicated NF clinicians including David Miller, MD, PhD, Debra Freedenberg, MD, PhD, Elizabeth Schorry, MD, Nicole Ullrich, MD, PhD, David Viskochil, MD, PhD, Bruce Korf, MD, PhD, Council on Genetics, American College of Medical Genetics and Genomics.
Dr. Miller led the working group that developed this paper and is also a collaborator on several projects with CTF, including co-funding Young Investigator Awards.
Miller DT, Freedenberg D, Schorry E, et al. AAP COUNCIL ON GENETICS, AAP AMERICAN COLLEGE OF MEDICAL GENETICS AND GENOMICS. Health Supervision for Children With Neurofibromatosis Type 1. Pediatrics. 2019;143(5): e20190660
